因子XI与复发性静脉血栓形成:一项观察性队列研究
在851例已停用抗凝的无诱因静脉血栓栓塞症(VTE)患者中,研究因子XI活性(FXIa)与VTE复发的关系。中位随访10年时,FXIa低于第34百分位者复发概率为31%,低于FXIa较高者(41%),且FXIa每降低10 IU dL-1,复发风险比为0.94(95%CI 0.89-0.99)。
要点
- FXIa每降低10 IU dL-1,VTE复发风险比为0.94(95%CI 0.89-0.99)。
- FXIa低于第34百分位者复发风险比为0.73(95%CI 0.54-0.99)。
- 10年复发概率:FXIa低于第34百分位为31%,第34至67百分位为43%,高于第67百分位为41%。
核心结论
- 低FXIa患者血栓风险较低且止血系统激活程度较轻,这与FXI是抗凝治疗有前景靶点的概念一致。
研究设计与样本
- 观察性队列研究,纳入851例已停用抗凝的无诱因VTE患者。
主要发现
- 265例患者记录到复发性VTE。
- FXIa每降低10 IU dL-1,性别和年龄校正的复发风险比为0.94(95%CI 0.89-0.99)。
- 与FXIa较高患者相比,FXIa低于第34百分位者复发风险比为0.73(95%CI 0.54-0.99),FXIa位于第34至67百分位者为1.05(95%CI 0.79-1.39)。
- FXIa低于第34百分位者复发概率低于FXIa较高者(P=0.029)。
- 10年复发概率在FXIa低于第34百分位、第34至67百分位和高于第67百分位者中分别为31%、43%和41%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials Factor XI is a potential target for anticoagulation. The association between factor XI and venous thrombosis recurrence was tested in a cohort study. Low factor XI was associated with reduced risk of recurrent venous thrombosis. A sex-and age-adjusted linear association between D-Dimer and factor XI was found. SUMMARY: Background and objectives Low factor XI activity (FXIa) reduces the risk of venous thromboembolism (VTE), and FXI is regarded as a potential target for anticoagulation. Patients/methods We studied the relationship between FXIa and VTE in 851 patients with unprovoked VTE in whom anticoagulation had been stopped. Results Recurrent VTE was recorded in 265 patients. The sex-adjusted and age-adjusted hazard ratio (HR) of recurrence was 0.94 (95% confidence interval [CI] 0.89-0.99) for each decrease of 10 IU dL-1 in FXIa. The HRs of recurrence were 0.73 (95% CI 0.54-0.99) for patients with FXIa below the 34th percentile, and 1.05 (95% CI 0.79-1.39) for patients with FXIa between the 34th and 67th percentiles, as compared with patients with higher FXIa. The probability of recurrence was lower among patients with FXIa below the 34th percentile than in patients with higher FXIa (P = 0.029). At 10 years, the probabilities of recurrence were 31%, 43% and 41% among patients with FXIa below the 34th percentile, with FXIa between the 34th and 67th percentiles, or with higher FXIa, respectively. We found a significant sex-adjusted and age-adjusted linear association between D-dimer levels, measured 3 weeks after anticoagulation, and FXIa. When patients' age and sex are taken into account, a patient with 10 IU dL-1 lower FXIa is expected to have a 2.79% (95% CI 0.95-4.59%) lower D-dimer value (P = 0.003). Conclusions Our findings of a lower thrombosis risk and less pronounced hemostatic system activation among patients with low FXIa is in line with the concept that FXI is a promising target for anticoagulation.
引用
- Kyrle PA, Eischer L, Šinkovec H, et al. Factor XI and recurrent venous thrombosis: an observational cohort study. J Thromb Haemost. 2019. PMID: 30784172. doi:10.1111/jth.14415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。